Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Abdominal Mesothelioma: Defining The Role Of Surgery

D. Rodríguez, M. Cheung, N. Housri, L. Koniaris
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Determine the role of surgery for patients with malignant abdominal mesotheliomas (MAMs).
This paper references
10.1002/cncr.21708
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion
S. Kusamura (2006)
10.1016/J.JAMCOLLSURG.2007.04.002
Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors.
J. C. Gutierrez (2007)
10.1002/ijc.23609
Long‐term mortality from pleural and peritoneal cancer after exposure to asbestos: Possible role of asbestos clearance
F. Barone-Adesi (2008)
10.1016/J.JAMCOLLSURG.2006.01.002
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
E. Perez (2006)
10.1002/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO;2-X
Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen
T. Mack (1995)
10.1056/NEJM198007243030407
Current concepts: malignant mesothelioma.
K. Antman (1980)
10.1002/1097-0142(19840201)53:3<377::AID-CNCR2820530302>3.0.CO;2-B
Malignant mesothelioma. The university of minnesota experience
N. Vogelzang (1984)
National mesothelioma incidence and the past use of asbestos.
A. Tossavainen (2003)
10.1007/s10434-999-0582-6
Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
B. Park (1999)
10.1053/EJSO.2001.1044
Peritoneal mesothelioma proposal for a staging system.
G. Sebbag (2001)
Seventeen year survival in a patient with malignant peritoneal mesothelioma.
J. Brenner (1981)
10.1002/cncr.21239
Diffuse malignant mesothelioma of the peritoneum
D. Nonaka (2005)
10.1179/oeh.2004.10.1.22
Global Use of Asbestos and the Incidence of Mesothelioma
A. Tossavainen (2004)
10.1053/SONC.2002.30236
Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience.
P. Sugarbaker (2002)
10.1002/cncr.10209
Diffuse malignant epithelial mesotheliomas of the peritoneum in women
S. Kerrigan (2002)
10.7326/0003-4819-96-6-746
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
A. Chahinian (1982)
10.1200/JCO.2003.04.150
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
A. Feldman (2003)
10.1245/ASO.2006.05.041
Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study
C. Brigand (2006)
10.1007/s11605-007-0417-3
Defining the Role of Surgery for Primary Gastrointestinal Tract Melanoma
M. Cheung (2007)
10.1002/JSO.20516
Inflammatory myofibroblastic tumors
S. Kovach (2006)
10.1016/J.JSS.2007.02.026
Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry.
J. C. Gutierrez (2007)
Malignant peritoneal mesothelioma: review of 25 patients.
J. Brenner (1981)
10.1007/s11605-006-0072-0
Surgical Outcomes of Gastrointestinal Sarcoma Including Gastrointestinal Stromal Tumors: A Population-based Examination
E. Perez (2006)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1002/JSO.10255
Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion
M. Deraco (2003)
10.1016/S1055-3207(03)00045-0
A review of peritoneal mesothelioma at the Washington Cancer Institute.
P. Sugarbaker (2003)
Prospective trial for the treatment of malignant peritoneal mesothelioma.
B. Loggie (2001)
10.1177/030089160308900307
Clinical Presentation of Peritoneal Mesothelioma
Y. Acherman (2003)
10.1002/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X
Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma
G. Eltabbakh (1999)
10.1007/s00383-007-1933-7
Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients
J. Gutiérrez (2007)
10.1007/s11605-007-0251-7
How Many Lymph Nodes Properly Stage a Periampullary Malignancy?
J. Gutiérrez (2007)
10.1016/J.HOC.2005.09.009
Prognostic factors for mesothelioma.
J. Steele (2005)
10.1007/s00464-005-0232-4
Gastric carcinoids: a temporal increase with proton pump introduction
N. Hodgson (2005)
10.1159/000199880
Malignant peritoneal mesothelioma: a series of 19 cases.
T. van Gelder (1989)
10.1097/01.sla.0000250438.04393.a8
Should Soft Tissue Sarcomas Be Treated at High-volume Centers?: An Analysis of 4205 Patients
J. C. Gutierrez (2007)
10.1002/PATH.1711720304
Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA)
M. Ramael (1994)
10.1001/ARCHSURG.1990.01410230071012
Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature.
J. Asensio (1990)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.20344/AMP.1970
[Malignant peritoneal mesothelioma -- diagnostic and therapeutic difficulties].
P. Cunha (2002)
10.1093/ANNONC/MDL345
Epidemiology of peritoneal mesothelioma: a review.
P. Boffetta (2007)
10.1007/s00268-005-0774-6
7201 Carcinoids: Increasing Incidence Overall and Disproportionate Mortality in the Elderly
E. Perez (2005)
10.1046/J.1365-2168.2000.01571.X
Results of treatment of 33 patients with peritoneal mesothelioma
G. Sebbag (2000)
10.1177/030089160509100101
Malignant peritoneal mesothelioma.
Vincenzo De Pangher Manzini (2005)
10.1016/S1092-9134(00)90036-4
Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma.
T. Beer (2000)
10.1002/IJC.2910410409
Survival patterns for malignant mesothelioma: The seer experience
R. Spirtas (1988)



This paper is referenced by
10.21037/jgo.2017.08.01
Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.
A. García-Fadrique (2017)
10.1200/JGO.2016.005280
Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure
Kirby R Qin (2017)
10.1016/J.GASTRE.2016.02.001
Peritoneal mesothelioma unmasked by an acute appendicitis
Eduardo Valdivielso Cortázar (2016)
10.2147/CMAR.S170300
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
Laura M Enomoto (2019)
10.1016/j.rmcr.2016.01.005
Malignant pleural mesothelioma in a 17-year old boy: A case report and literature review
C. Pérez-Guzmán (2016)
10.18632/ONCOTARGET.4414
Distinctive clinical characteristics of malignant mesothelioma in young patients
A. Thomas (2015)
10.1007/s12328-017-0757-9
A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis
Hirokazu Saito (2017)
10.4103/2303-9027.170453
Malignant peritoneal mesothelioma diagnosed by EUS-guided tissue acquisition
D. Mohri (2015)
10.1007/s13577-019-00286-w
Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance
T. Akahane (2019)
10.1245/s10434-014-3803-6
Current Trends in the Management of Malignant Peritoneal Mesothelioma
J. Miura (2014)
10.1590/S1677-5538.IBJU.2018.0815
Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
Cem Başataç (2019)
10.1590/0102-311X00171917
[A proposal for the creation of a system to monitor cases of malignant mesothelioma in Curitiba, Paraná, Brazil].
Luciana Puchalski Kalinke (2018)
10.1200/EdBook_AM.2013.33.182
Peritoneal mesothelioma: the site of origin matters.
H. Kindler (2013)
10.1016/j.gastrohep.2015.01.008
[Peritoneal mesothelioma unmasked by an acute appendicitis].
Eduardo Valdivielso Cortázar (2016)
10.14309/crj.2018.23
Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites
Zachary Field (2018)
10.3748/wjg.v20.i33.11700
Advances in the management of peritoneal mesothelioma.
A. Raza (2014)
10.1007/s12328-019-01051-0
Localized biphasic malignant peritoneal mesothelioma presenting as a rectal tumor
K. Saisho (2019)
10.1016/J.JURO.2012.02.753
672 PRIMARY SPERMATIC CORD TUMORS DISEASE CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOMES
D. Rodríguez (2012)
10.1245/s10434-018-6499-1
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival
V. Verma (2018)
10.12669/pjms.296.3938
Malignant mesothelioma
Ishtiaq Ahmed (2013)
10.1080/14737140.2017.1340157
First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma
Eriko Fujimoto (2017)
10.1590/0102-311X00171917
Uma proposta de criação de um sistema para monitoramento dos casos de mesotelioma maligno em Curitiba, Paraná, Brasil
Luciana Puchalski Kalinke (2018)
10.1097/PAS.0000000000000495
Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases
E. Pavlisko (2015)
10.1007/s12328-012-0334-1
Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy
K. Nakashima (2012)
10.1200/JGO.2016.007476
Cancer Trends in Mexico: Essential Data for the Creation and Follow-Up of Public Policies
A. Mohar-Betancourt (2017)
Calcificaciones groseras hepáticas como forma de presentación de un mesotelioma maligno peritoneal
Carmen Lara Romero (2017)
10.1002/jcb.25095
Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure
J. Dragon (2015)
10.1136/bcr-2013-200212
Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature
J. Mino (2014)
10.1016/J.GASTROHEP.2015.01.008
Mesotelioma epitelioide peritoneal desenmascarado por una apendicitis aguda
Eduardo Valdivielso Cortázar (2016)
10.1097/CAD.0000000000000106
Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma.
S. Kruger (2014)
Presentation of a malignant peritoneal mesothelioma in the forma of rough hepatic calcifications.
Carmen Lara Romero (2017)
10.1016/j.gore.2020.100642
A case of sarcomatoid malignant peritoneal mesothelioma diagnosed by laparoscopy
Mariya Kobayashi (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar